BIOS logo

BioPlus Acquisition (BIOS) Selling, General & Administrative Expenses

BIOS Annual SG&A

N/A

31 December 2022

All-time High

$525.71 M
BIOS annual selling, general & administrative expenses is currently at an all-time high
Annual Total Expenses$1.17 M
BIOS annual total expenses is $1.17 million
Annual Operating Expenses$1.17 M
BIOS annual total operating expenses is $1.17 million
Annual Net Income$2.00 M
BIOS annual net profit is $2.00 million

BIOS Selling, General & Administrative Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BIOS Quarterly SG&A

N/A

30 June 2023

All-time High

$311.80 M
BIOS quarterly selling, general & administrative expenses is currently at an all-time high
Quarterly Total Expenses$1.28 M
BIOS quarterly total expenses is $1.28 million
Quarterly Operating Expenses$1.28 M
BIOS quarterly total operating expenses is $1.28 million
Quarterly Net Income$1.24 M
BIOS quarterly net profit is $1.24 million

BIOS Quarterly SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BIOS TTM SG&A

-$60.88 M
-$2.41 M-4.13%

30 June 2023

3-Year Change

-111.45%
BIOS TTM selling, general & administrative expenses is down -111.45% over the past 3 years

All-time High

$539.86 M
BIOS TTM selling, general & administrative expenses is currently -111.28% below its historical high of $539.86 million
Annual Total Expenses$1.17 M
BIOS annual total expenses is $1.17 million
Annual Operating Expenses$1.17 M
BIOS annual total operating expenses is $1.17 million
TTM Net Income$5.79 M
BIOS TTM net profit is $5.79 million

BIOS TTM SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BIOS Selling, General & Administrative Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---111.5%
5 y5 years---116.4%

BIOS Selling, General & Administrative Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time-111.3%

BioPlus Acquisition Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sept 2022
-
$290.40 K(>+9900.0%)
$290.40 K(-99.8%)
Dec 2021
$525.71 M(+5.1%)
-
-
Sept 2021
-
$900.00(-18.2%)
$123.00 M(-50.0%)
June 2021
-
$1100.00(-100.0%)
$246.00 M(-50.8%)
Dec 2020
$500.20 M(+8.8%)
$123.00 M(+0.0%)
$500.20 M(-4.0%)
Sept 2020
-
$123.00 M(-1.5%)
$521.01 M(-2.0%)
June 2020
-
$124.92 M(-3.4%)
$531.49 M(+27.0%)
Mar 2020
-
$129.28 M(-10.1%)
$418.36 M(+12.5%)
Dec 2019
$459.63 M(+32.9%)
$143.81 M(+7.7%)
$371.87 M(-31.1%)
Sept 2019
-
$133.47 M(+1031.5%)
$539.86 M(+28.9%)
June 2019
-
$11.80 M(-85.8%)
$418.86 M(+0.2%)
Mar 2019
-
$82.79 M(-73.4%)
$418.00 M(+20.9%)
Dec 2018
$345.88 M(+772.9%)
$311.80 M(+2398.8%)
$345.88 M(+662.2%)
Sept 2018
-
$12.48 M(+14.2%)
$45.38 M(+7.3%)
June 2018
-
$10.93 M(+2.5%)
$42.30 M(+3.1%)
Mar 2018
-
$10.67 M(-5.6%)
$41.03 M(+3.5%)
Dec 2017
$39.63 M(+2.1%)
$11.30 M(+20.1%)
$39.63 M(+7.9%)
Sept 2017
-
$9.40 M(-2.6%)
$36.71 M(-1.5%)
June 2017
-
$9.65 M(+4.2%)
$37.25 M(+0.6%)
Mar 2017
-
$9.27 M(+10.5%)
$37.01 M(-4.6%)
Dec 2016
$38.80 M(-8.7%)
$8.38 M(-15.7%)
$38.80 M(-5.4%)
Sept 2016
-
$9.95 M(+5.7%)
$41.01 M(+3.5%)
June 2016
-
$9.41 M(-14.8%)
$39.60 M(-5.8%)
Mar 2016
-
$11.05 M(+4.3%)
$42.06 M(-1.5%)
Dec 2015
$42.47 M(-13.9%)
$10.59 M(+23.9%)
$42.70 M(-150.1%)
Sept 2015
-
$8.55 M(-28.0%)
-$85.23 M(+126.1%)
June 2015
-
$11.87 M(+1.4%)
-$37.69 M(-590.4%)
Mar 2015
-
$11.70 M(-110.0%)
$7.69 M(-86.1%)
Dec 2014
$49.31 M(+3.0%)
-$117.35 M(-309.2%)
$55.17 M(-22.0%)
Sept 2014
-
$56.09 M(-2.0%)
$70.74 M(+5.4%)
June 2014
-
$57.24 M(-3.3%)
$67.10 M(+11.6%)
Mar 2014
-
$59.18 M(-158.1%)
$60.16 M(+25.4%)
Dec 2013
$47.90 M(-70.6%)
-$101.77 M(-294.0%)
$47.98 M(-72.9%)
Sept 2013
-
$52.45 M(+4.3%)
$177.23 M(+3.3%)
June 2013
-
$50.30 M(+7.0%)
$171.55 M(+3.8%)
Mar 2013
-
$47.01 M(+71.1%)
$165.31 M(+1.5%)
Dec 2012
$162.88 M(-2.5%)
$27.48 M(-41.3%)
$162.88 M(-8.7%)
Sept 2012
-
$46.77 M(+6.2%)
$178.38 M(+2.6%)
June 2012
-
$44.06 M(-1.2%)
$173.94 M(+2.1%)
Mar 2012
-
$44.58 M(+3.7%)
$170.31 M(+0.3%)
Dec 2011
$167.14 M(+25.3%)
$42.97 M(+1.5%)
$169.79 M(+50.0%)
Sept 2011
-
$42.34 M(+4.7%)
$113.22 M(-10.7%)
June 2011
-
$40.43 M(-8.2%)
$126.84 M(-12.3%)
Mar 2011
-
$44.05 M(-424.0%)
$144.66 M(+5.6%)
Dec 2010
$133.38 M(+1.1%)
-
-
Dec 2010
-
-$13.60 M(-124.3%)
$136.96 M(-27.2%)
Sept 2010
-
$55.95 M(-4.0%)
$188.17 M(+14.3%)
June 2010
-
$58.25 M(+60.2%)
$164.62 M(+19.3%)
Mar 2010
-
$36.35 M(-3.3%)
$137.97 M(+4.6%)
Dec 2009
$131.95 M(+5.4%)
-
-
Dec 2009
-
$37.61 M(+16.1%)
$131.95 M(+7.1%)
Sept 2009
-
$32.40 M(+2.5%)
$123.17 M(-0.3%)
June 2009
-
$31.61 M(+4.2%)
$123.56 M(-0.0%)
Mar 2009
-
$30.33 M(+5.2%)
$123.59 M(-1.1%)
Dec 2008
$125.20 M
-
-
Dec 2008
-
$28.84 M(-12.1%)
$124.96 M(-3.0%)
Sept 2008
-
$32.79 M(+3.6%)
$128.76 M(+0.8%)
June 2008
-
$31.64 M(-0.2%)
$127.71 M(+1.4%)
DateAnnualQuarterlyTTM
Mar 2008
-
$31.70 M(-2.9%)
$125.99 M(+0.6%)
Dec 2007
$125.27 M(-1.9%)
-
-
Dec 2007
-
$32.64 M(+2.9%)
$125.27 M(+2.1%)
Sept 2007
-
$31.73 M(+6.0%)
$122.63 M(-0.2%)
June 2007
-
$29.92 M(-3.4%)
$122.94 M(-4.3%)
Mar 2007
-
$30.97 M(+3.2%)
$128.47 M(+0.6%)
Dec 2006
$127.70 M(+16.7%)
-
-
Dec 2006
-
$30.01 M(-6.3%)
$127.68 M(-5.6%)
Sept 2006
-
$32.04 M(-9.6%)
$135.30 M(+3.1%)
June 2006
-
$35.45 M(+17.5%)
$131.21 M(+6.4%)
Mar 2006
-
$30.18 M(-19.8%)
$123.34 M(+12.7%)
Dec 2005
$109.44 M(+107.1%)
-
-
Dec 2005
-
$37.63 M(+34.7%)
$109.44 M(+26.2%)
Sept 2005
-
$27.94 M(+1.3%)
$86.71 M(+21.1%)
June 2005
-
$27.59 M(+69.4%)
$71.61 M(+26.5%)
Mar 2005
-
$16.28 M(+9.3%)
$56.63 M(+7.2%)
Dec 2004
$52.84 M(+4.4%)
-
-
Dec 2004
-
$14.90 M(+16.0%)
$52.84 M(+3.6%)
Sept 2004
-
$12.84 M(+1.9%)
$51.01 M(+0.5%)
June 2004
-
$12.61 M(+0.9%)
$50.75 M(-0.3%)
Mar 2004
-
$12.49 M(-4.3%)
$50.90 M(+0.5%)
Dec 2003
$50.63 M(+10.4%)
-
-
Dec 2003
-
$13.06 M(+3.8%)
$50.63 M(-0.1%)
Sept 2003
-
$12.59 M(-1.3%)
$50.66 M(+1.7%)
June 2003
-
$12.75 M(+4.3%)
$49.80 M(+3.4%)
Mar 2003
-
$12.23 M(-6.6%)
$48.17 M(+5.0%)
Dec 2002
$45.88 M(+19.2%)
-
-
Dec 2002
-
$13.09 M(+11.6%)
$45.88 M(+5.0%)
Sept 2002
-
$11.73 M(+5.5%)
$43.67 M(+4.6%)
June 2002
-
$11.12 M(+12.0%)
$41.77 M(+4.4%)
Mar 2002
-
$9.93 M(-8.8%)
$40.02 M(+4.0%)
Dec 2001
$38.49 M(+13.5%)
-
-
Dec 2001
-
$10.89 M(+10.8%)
$38.49 M(-0.8%)
Sept 2001
-
$9.83 M(+4.9%)
$38.81 M(+1.7%)
June 2001
-
$9.37 M(+11.5%)
$38.15 M(+5.7%)
Mar 2001
-
$8.40 M(-25.1%)
$36.09 M(+6.4%)
Dec 2000
$33.91 M(+21.1%)
-
-
Dec 2000
-
$11.22 M(+22.4%)
$33.93 M(+16.5%)
Sept 2000
-
$9.16 M(+25.4%)
$29.12 M(+7.6%)
June 2000
-
$7.31 M(+17.2%)
$27.06 M(+0.8%)
Mar 2000
-
$6.24 M(-2.7%)
$26.85 M(-4.5%)
Dec 1999
$28.01 M(+21.3%)
-
-
Dec 1999
-
$6.41 M(-9.7%)
$28.11 M(-4.7%)
Sept 1999
-
$7.10 M(0.0%)
$29.50 M(+3.5%)
June 1999
-
$7.10 M(-5.3%)
$28.50 M(+8.8%)
Mar 1999
-
$7.50 M(-3.8%)
$26.20 M(+12.9%)
Dec 1998
$23.10 M(+20.9%)
-
-
Dec 1998
-
$7.80 M(+27.9%)
$23.20 M(+8.4%)
Sept 1998
-
$6.10 M(+27.1%)
$21.40 M(+4.4%)
June 1998
-
$4.80 M(+6.7%)
$20.50 M(+4.1%)
Mar 1998
-
$4.50 M(-25.0%)
$19.70 M(+3.1%)
Dec 1997
$19.10 M(-50.0%)
-
-
Dec 1997
-
$6.00 M(+15.4%)
$19.10 M(+12.4%)
Sept 1997
-
$5.20 M(+30.0%)
$17.00 M(+14.9%)
June 1997
-
$4.00 M(+2.6%)
$14.80 M(+37.0%)
Mar 1997
-
$3.90 M(0.0%)
$10.80 M(+56.5%)
Dec 1996
$38.20 M
-
-
Dec 1996
-
$3.90 M(+30.0%)
$6.90 M(+130.0%)
Sept 1996
-
$3.00 M
$3.00 M

FAQ

  • What is the all time high annual SG&A for BioPlus Acquisition?
  • What is the all time high quarterly SG&A for BioPlus Acquisition?
  • What is BioPlus Acquisition TTM selling, general & administrative expenses?
  • What is the all time high TTM SG&A for BioPlus Acquisition?

What is the all time high annual SG&A for BioPlus Acquisition?

BioPlus Acquisition all-time high annual selling, general & administrative expenses is $525.71 M

What is the all time high quarterly SG&A for BioPlus Acquisition?

BioPlus Acquisition all-time high quarterly selling, general & administrative expenses is $311.80 M

What is BioPlus Acquisition TTM selling, general & administrative expenses?

The current TTM SG&A of BIOS is -$60.88 M

What is the all time high TTM SG&A for BioPlus Acquisition?

BioPlus Acquisition all-time high TTM selling, general & administrative expenses is $539.86 M